DocuSign, Inc. (NASDAQ:DOCU) Shares Sold by ExodusPoint Capital Management LP

ExodusPoint Capital Management LP decreased its position in shares of DocuSign, Inc. (NASDAQ:DOCU) by 87.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 29,387 shares of the company’s stock after selling 202,629 shares during the quarter. ExodusPoint Capital Management LP’s holdings in DocuSign were worth $2,643,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of the company. Janus Henderson Group PLC increased its stake in shares of DocuSign by 13.1% in the third quarter. Janus Henderson Group PLC now owns 12,110 shares of the company’s stock valued at $752,000 after purchasing an additional 1,398 shares during the period. Royal London Asset Management Ltd. increased its position in DocuSign by 4.5% in the 3rd quarter. Royal London Asset Management Ltd. now owns 80,490 shares of the company’s stock valued at $4,998,000 after acquiring an additional 3,466 shares during the period. State Street Corp raised its stake in DocuSign by 2.3% during the 3rd quarter. State Street Corp now owns 5,372,939 shares of the company’s stock valued at $333,604,000 after acquiring an additional 120,743 shares in the last quarter. Kovitz Investment Group Partners LLC acquired a new position in DocuSign during the 3rd quarter worth $350,000. Finally, EP Wealth Advisors LLC bought a new position in shares of DocuSign in the third quarter worth $205,000. Institutional investors own 77.64% of the company’s stock.

DocuSign Trading Down 0.4 %

DOCU stock opened at $71.95 on Tuesday. DocuSign, Inc. has a one year low of $48.70 and a one year high of $107.86. The firm has a 50-day moving average of $85.61 and a two-hundred day moving average of $82.45. The firm has a market capitalization of $14.57 billion, a PE ratio of 14.84, a P/E/G ratio of 6.94 and a beta of 1.20.

DocuSign (NASDAQ:DOCU) last issued its quarterly earnings results on Thursday, March 13th. The company reported $0.86 EPS for the quarter, beating the consensus estimate of $0.84 by $0.02. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The business had revenue of $776.25 million during the quarter, compared to the consensus estimate of $760.94 million. During the same quarter in the prior year, the firm earned $0.76 EPS. The firm’s quarterly revenue was up 9.0% on a year-over-year basis. On average, equities research analysts anticipate that DocuSign, Inc. will post 1.17 earnings per share for the current year.

Insider Buying and Selling

In other DocuSign news, Director Peter Solvik sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $91.26, for a total value of $912,600.00. Following the transaction, the director now owns 150,253 shares in the company, valued at approximately $13,712,088.78. This represents a 6.24 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Teresa Briggs sold 534 shares of the stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $87.41, for a total transaction of $46,676.94. Following the completion of the sale, the director now owns 8,270 shares of the company’s stock, valued at approximately $722,880.70. The trade was a 6.07 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 57,851 shares of company stock valued at $4,911,319. Corporate insiders own 1.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on DOCU. Jefferies Financial Group decreased their target price on shares of DocuSign from $115.00 to $105.00 and set a “buy” rating for the company in a research report on Monday, March 31st. Wells Fargo & Company raised their price objective on shares of DocuSign from $70.00 to $73.00 and gave the company an “underweight” rating in a research note on Friday, March 14th. William Blair upgraded DocuSign from a “market perform” rating to an “outperform” rating in a research report on Monday, March 17th. Citigroup upped their price objective on DocuSign from $113.00 to $115.00 and gave the company a “buy” rating in a report on Friday, March 14th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $90.00 target price on shares of DocuSign in a research note on Friday, March 14th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, DocuSign currently has a consensus rating of “Hold” and an average target price of $95.83.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.